查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949563

電生理市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、適應症、最終用戶、地區和競爭格局分類），2021-2031年

Electrophysiology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球電生理市場預計將從 2025 年的 93.8 億美元成長到 2031 年的 191.1 億美元，複合年成長率達到 12.59%。

電生理學是心臟病學的一個分支，它透過分析心臟的電活動來診斷和治療心律不整。此領域主要利用診斷導管、消融導管和標測系統來矯正心房顫動等心律不整，並恢復正常的心臟功能。全球人口老化和需要介入治療的慢性心臟疾病患者數量不斷增加，是推動該領域發展的主要因素。例如，心律學會 (HRS) 估計，到 2025 年，美國將有約 1,050 萬成年人患有心房顫動，這意味著需要接受電生理治療的患者群體將顯著擴大。

市場概覽
預測期 2027-2031
市場規模：2025年 93.8億美元
市場規模：2031年 191.1億美元
複合年成長率：2026-2031年 12.59%
成長最快的細分市場 電生理診斷導管
最大的市場 北美洲

然而，阻礙該市場快速擴張的主要障礙是熟練的電生理學家和執行這些複雜手術所需的專業人員短缺。掌握消融技術需要漫長的培訓，造成了人才瓶頸，限制了醫療機構每年可進行的手術數量。合格人員的短缺限制了患者獲得救命治療的機會，也限制了全球製造商和醫療保健提供者的潛在收入成長。

市場促進因素

心房顫動（心房顫動）和心律不整的日益普遍是全球電生理市場的主要驅動力。人口結構的變化，包括全球人口老化和高血壓等生活方式相關風​​險因素的增加，正在推動複雜心律不整發病率的激增。患者群體的擴大導致對診斷和治療性介入的需求增加，進而推動了對先進消融導管和標測系統的需求。根據Medtronic2024年5月發布的關於其PulseSelect脈衝電場消融系統在日本核准的新聞稿，全球有超過6000萬人患有房顫，這凸顯了全球範圍內對有效電生理解決方案的迫切需求。

同時，持續的產品創新和關鍵監管核准正在提升手術的安全性和效率，加速市場擴張。脈衝電場消融（PFA）技術的近期商業化標誌著一個關鍵轉折點，促使醫療機構迅速採用該技術以最佳化臨床療效和患者周轉率。隨著醫院升級其檢查室，這波創新浪潮正轉化為領先製造商的顯著收入成長。例如，波士頓科學公司在2024年10月發布的「2024年第三季財務與業績亮點」報告中指出，其電生理業務淨銷售額年增177%，這主要得益於其新型消融產品組合的強勁表現。同樣，雅培公司的電生理部門在2024年第三季實現了14.3%的有機銷售額成長，進一步印證了該產業的上升趨勢。

市場挑戰

熟練的電生理醫師和專業檢查室人員短缺是限制市場成長的主要因素。電生理手術，尤其是消融和標測等手術，技術難度極高，需要操作人員接受廣泛而深入的培訓，以確保病人安全和手術成功。這種陡峭的學習曲線造成了勞動力供應的嚴重瓶頸，因為新入行的專業人員數量無法跟上需要治療的患者數量的成長。因此，即使擁有先進的設備，醫療機構的手術能力也受到限制，能夠進行的手術數量也受到限制。

人才短缺直接影響市場收入，限制了新技術的普及，並延長了患者接受所需治療的等待時間。當醫院缺乏足夠的合格人員時，已安裝的系統無法充分利用，導致資本資產利用率低下，錯失了商機。根據英國心臟基金會預測，到2024年，英格蘭等待心臟檢查和治療的患者人數預計將達到約40萬的歷史新高，凸顯了人才短缺的嚴重性。這些延誤迫使醫療機構只能優先處理最緊急的病例，導致整體手術量下降，並抑制了全球對電生理設備的需求。

市場趨勢

將人工智慧 (AI) 整合到心臟定位系統中，正從根本上改變全球電生理市場，顯著提升診斷準確性和手術效率。製造商正將機器學習演算法融入標測平台，以自動識別複雜的心律不整基材，減少操作人員的手動操作，並提高訊號解讀的準確性。這項技術突破實現了即時解剖建模和異位起搏點的快速識別，而這對於消融治療的成功至關重要。根據 Biosense Webster 公司於 2024 年 5 月發布的「Carto 3 系統版本 8」的產品資訊，該公司已推出其最新的標測軟體「CartoSound FAM 模組」。此模組利用人工智慧自動產生左心房解剖結構，顯著簡化了心導管電氣燒灼術手術的流程。

同時，降低醫療成本的需求正在加速電生理手術轉移到門診手術中心（ASC）的情況。隨著心導管電氣燒灼術安全性的提高，醫療系統正將常規手術從高成本的醫院門診轉移到成本效益更高的門診手術中心。這種轉變的經濟獎勵來自於有利的報銷機制，該機制在不影響臨床品質的前提下最佳化了資源配置。根據心律介入學會2024年9月題為《門診手術中心心臟電生理手術的安全性和可行性》的信函，美國醫療保險和醫療補助服務中心（CMS）的支付分析顯示，在醫院門診部進行的心臟電生理手術的成本比在門診手術中心進行的同類手術高出36%，這印證了推動這一轉變的經濟效益。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球電生理市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（電生理消融導管、電生理診斷導管、電生理檢查室設備、通路裝置）
    • 依適應症（心房顫動、心室性心搏過速、心房心搏過速、心房撲動、預激症候群（WPW）、房室結折返性心搏過速（AVNRT）、其他）
    • 按最終使用者（醫院和心臟中心、門診手術中心）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美電生理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲電生理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區電生理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲電生理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲電生理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球電生理市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Johnson & Johnson Services, Inc.
  • BIOTRONIK SE & Co KG
  • Medtronic Plc.
  • Boston Scientific Corporation
  • B. Braun SE
  • Koninklijke Philips NV
  • Medline Industries, LP.
  • Siemens Healthineers AG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23734

The Global Electrophysiology Market is projected to expand from USD 9.38 Billion in 2025 to USD 19.11 Billion by 2031, achieving a compound annual growth rate of 12.59%. Electrophysiology is a specialized field within cardiology dedicated to diagnosing and treating heart rhythm disorders by analyzing the heart's electrical activity. The market primarily utilizes diagnostic catheters, ablation catheters, and mapping systems to correct arrhythmias like atrial fibrillation and restore normal cardiac function. This sector's growth is fundamentally driven by an aging global population and the increasing prevalence of chronic cardiac conditions requiring procedural intervention. For instance, the Heart Rhythm Society estimates that in 2025, atrial fibrillation will affect approximately 10.5 million adults in the United States, indicating a significant and growing patient base needing electrophysiological care.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 9.38 Billion
Market Size 2031USD 19.11 Billion
CAGR 2026-203112.59%
Fastest Growing SegmentElectrophysiology Diagnostic Catheters
Largest MarketNorth America

However, a major obstacle hindering the rapid expansion of this market is the shortage of skilled electrophysiologists and specialized staff needed to perform these complex procedures. The extensive training required to master ablation techniques creates a workforce bottleneck that limits the number of treatments medical facilities can conduct annually. This scarcity of qualified personnel restricts patient access to life-saving therapies and constrains potential revenue growth for manufacturers and healthcare providers globally.

Market Driver

The escalating prevalence of atrial fibrillation (AFib) and cardiac arrhythmias acts as the primary catalyst for the Global Electrophysiology Market. As demographic shifts lead to an aging global population and lifestyle-related risk factors like hypertension increase, the incidence of complex rhythm disorders is surging. This expansion of the patient pool necessitates a higher volume of diagnostic and therapeutic interventions, thereby fueling demand for advanced ablation catheters and mapping systems. According to a May 2024 press release by Medtronic regarding the approval of its PulseSelect pulsed field ablation system in Japan, atrial fibrillation affects more than 60 million people worldwide, highlighting the critical need for effective electrophysiological solutions on a global scale.

Simultaneously, continuous product innovation and the acquisition of key regulatory clearances are accelerating market expansion by enhancing procedural safety and efficiency. The recent commercialization of Pulsed Field Ablation (PFA) technologies represents a significant shift, encouraging rapid adoption by healthcare facilities seeking to optimize clinical outcomes and patient turnover. This wave of technological advancement is translating into substantial financial gains for leading manufacturers as hospitals upgrade their laboratories. For instance, Boston Scientific reported in its 'Q3 2024 Financial & Operational Highlights' in October 2024 that its Electrophysiology business segment saw a 177% year-over-year net sales increase, driven by its novel ablation portfolio. Similarly, Abbott's electrophysiology division achieved organic sales growth of 14.3% in the third quarter of 2024, further evidencing the sector's upward trajectory.

Market Challenge

The shortage of skilled electrophysiologists and specialized laboratory staff presents a primary constraint on the market's trajectory. Electrophysiology procedures, particularly those involving ablation and mapping, are highly technical and require operators to undergo extensive and prolonged training to ensure patient safety and procedural success. This steep learning curve creates a rigid bottleneck in the workforce supply, as the rate at which new specialists enter the field fails to keep pace with the growing volume of patients requiring treatment. Consequently, medical facilities face a capped capacity for performing procedures, restricting the volume of interventions possible regardless of the availability of advanced equipment.

This labor deficit directly impacts market revenue by limiting the adoption rate of new technologies and extending patient wait times for necessary interventions. When hospitals lack sufficient qualified personnel, they cannot fully utilize installed systems, leading to underutilization of capital assets and missed revenue opportunities. According to the British Heart Foundation, in 2024, the number of people waiting for heart tests and treatments in England reached a record high of approximately 400,000, underscoring the critical workforce deficits. Such delays force healthcare providers to prioritize only the most critical cases, thereby slowing the overall procedural volume and tempering the demand for electrophysiology devices globally.

Market Trends

The Integration of Artificial Intelligence in Cardiac Mapping Systems is fundamentally reshaping the Global Electrophysiology Market by enhancing diagnostic precision and procedural efficiency. Manufacturers are embedding machine learning algorithms into mapping platforms to automate the identification of complex arrhythmia substrates, reducing operator manual workload and interpreting signal data with greater accuracy. This technological leap allows for real-time anatomical modeling and faster localization of ectopic foci, which is critical for successful ablation outcomes. According to Biosense Webster's May 2024 product announcement for the 'Carto 3 System Version 8', the company launched its latest mapping software featuring the CartoSound FAM module, which utilizes artificial intelligence to automatically generate left atrial anatomy and significantly streamline the workflow for catheter ablation procedures.

Concurrently, the Shift of Electrophysiology Procedures to Ambulatory Surgical Centers (ASCs) is accelerating, driven by the imperative to reduce healthcare expenditures. As safety profiles for catheter ablations improve, healthcare systems are migrating routine interventions from high-cost hospital outpatient departments to cost-effective ASC environments. This transition is financially incentivized by favorable reimbursement structures that optimize resource allocation without compromising clinical quality. According to a September 2024 letter from the Arrhythmia Intervention Society titled 'Safety and Feasibility of Cardiac Electrophysiology Procedures In Ambulatory Surgery Centers', an analysis of CMS payments revealed that cardiac electrophysiology procedures performed in hospital outpatient departments incurred a 36% cost increase compared to those conducted in ambulatory surgical centers, underscoring the economic benefits fueling this shift.

Key Market Players

  • Johnson & Johnson Services, Inc.
  • BIOTRONIK SE & Co KG
  • Medtronic Plc.
  • Boston Scientific Corporation
  • B. Braun SE
  • Koninklijke Philips N.V.
  • Medline Industries, LP.
  • Siemens Healthineers AG

Report Scope

In this report, the Global Electrophysiology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Electrophysiology Market, By Product

  • Electrophysiology Ablation Catheters
  • Electrophysiology Diagnostic Catheters
  • Electrophysiology Laboratory Devices
  • Access Devices

Electrophysiology Market, By Indication

  • Atrial Fibrillation
  • Ventricular Tachycardia
  • Atrial Tachycardia
  • Atrial Flutter
  • WOLFF-Parkinson-White (WPW) Syndrome
  • Atrioventricular Nodal Reentry Tachycardia (AVNRT)
  • Others

Electrophysiology Market, By End User

  • Hospitals and Cardiac Centres
  • Ambulatory Surgery Centres

Electrophysiology Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Electrophysiology Market.

Available Customizations:

Global Electrophysiology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Electrophysiology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices)
    • 5.2.2. By Indication (Atrial Fibrillation, Ventricular Tachycardia, Atrial Tachycardia, Atrial Flutter, WOLFF-Parkinson-White (WPW) Syndrome, Atrioventricular Nodal Reentry Tachycardia (AVNRT), Others)
    • 5.2.3. By End User (Hospitals and Cardiac Centres, Ambulatory Surgery Centres)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Electrophysiology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Indication
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Electrophysiology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Electrophysiology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Electrophysiology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By End User

7. Europe Electrophysiology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Indication
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Electrophysiology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By End User
    • 7.3.2. France Electrophysiology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Electrophysiology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Electrophysiology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Electrophysiology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By End User

8. Asia Pacific Electrophysiology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Electrophysiology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By End User
    • 8.3.2. India Electrophysiology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Electrophysiology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Electrophysiology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Electrophysiology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By End User

9. Middle East & Africa Electrophysiology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Indication
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Electrophysiology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Electrophysiology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Electrophysiology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By End User

10. South America Electrophysiology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Indication
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Electrophysiology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Electrophysiology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Electrophysiology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Electrophysiology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Johnson & Johnson Services, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. BIOTRONIK SE & Co KG
  • 15.3. Medtronic Plc.
  • 15.4. Boston Scientific Corporation
  • 15.5. B. Braun SE
  • 15.6. Koninklijke Philips N.V.
  • 15.7. Medline Industries, LP.
  • 15.8. Siemens Healthineers AG

16. Strategic Recommendations

17. About Us & Disclaimer